骶骨阴道固定术与子宫骶韧带悬吊术后的脱垂复发:按盆腔器官脱垂定量分期分层比较
在一个大型学术中心比较2009至2015年接受微创骶骨阴道固定术或子宫骶韧带悬吊术的女性,按术前盆腔器官脱垂定量分期分层分析复发率。结果显示,III期脱垂患者行子宫骶韧带悬吊术的复发率更高,校正混杂因素后比值比为4.3(95%CI 2.2-8.2),而II期患者两种术式复发率相似。
要点
- III期脱垂患者行子宫骶韧带悬吊术的复发率高于骶骨阴道固定术,校正后OR为4.3(95%CI 2.2-8.2)。
- II期脱垂患者两种术式复发率相似(6.0% vs 5.0%,P=1.00)。
- IV期脱垂患者两种术式复发率未见明显差异,但样本量有限。
核心结论
- 对于III期脱垂,骶骨阴道固定术的脱垂复发率低于子宫骶韧带悬吊术。
- 对于术前II期脱垂,两种术式复发率无差异,提示这些患者可能不需要补片加强。
- 需要更大规模的前瞻性试验来确认。
研究设计与样本
- 比较2009年至2015年在一个大型学术中心接受微创骶骨阴道固定术或经阴道或微创子宫骶韧带悬吊术的所有女性。
- 纳入所有有术前和术后盆腔器官脱垂定量数据的女性,按术前分期分组分析。
- 共756名女性,其中633名(83.7%)接受骶骨阴道固定术,123名(16.3%)接受子宫骶韧带悬吊术。
- 189名(25%)为术前II期脱垂,527名(69.7%)为III期,40名(5.3%)为IV期。
- 中位随访41.0周(四分位距13.0-88.8周)。
主要发现
- 与子宫骶韧带悬吊术患者相比,更多骶骨阴道固定术患者曾接受过脱垂修复(20.9% vs 5.7%,P < .001),且已知糖尿病者更少(7.9% vs 13.8%,P = .034)。
- II期脱垂患者行骶骨阴道固定术或子宫骶韧带悬吊术的复发率相似(6.0% vs 5.0%,P = 1.00)。
- III期脱垂患者行子宫骶韧带悬吊术更可能出现复发(25.7% vs 7.8%,P < .001)。
- 校正年龄、体重指数、吸烟、糖尿病和既往脱垂修复后,该差异持续存在(比值比4.3;95%置信区间2.2-8.2)。
- IV期脱垂女性的复发率未见明显差异,但样本量有限。
关键数值与推荐
- 脱垂复发定义为因脱垂接受任何再治疗或任何盆腔器官脱垂定量点超过处女膜。
- III期脱垂患者行子宫骶韧带悬吊术对比骶骨阴道固定术的复发比值比为4.3(95%置信区间2.2-8.2)。
临床怎么用
- 对于III期脱垂,骶骨阴道固定术的脱垂复发率低于子宫骶韧带悬吊术。
- 对于术前II期脱垂,两种术式复发率无差异,作者认为补片加强可能不适用于这些患者。
- 需要更大规模的前瞻性试验来确认。
局限性
- IV期脱垂分析样本量有限。
- 需要更大规模的前瞻性试验来确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Insufficient evidence evaluates which pelvic organ prolapse surgery is best suited to an individual woman based on the stage of her prolapse. OBJECTIVE: We sought to compare prolapse recurrence rates following sacrocolpopexy and uterosacral ligament suspension after stratifying by preoperative Pelvic Organ Prolapse Quantification stage. STUDY DESIGN: We compared all women who underwent minimally invasive sacrocolpopexy or vaginal or minimally invasive uterosacral ligament suspension from 2009 through 2015 at a large academic center. All women with preoperative and postoperative Pelvic Organ Prolapse Quantification data were included. Patients were grouped by preoperative Pelvic Organ Prolapse Quantification stage for analysis. Recurrence rates following sacrocolpopexy and uterosacral ligament suspension were compared for patients presenting with stage II, III, and IV prolapse, adjusting for potential confounders in regression models. Prolapse recurrence was defined as any retreatment for prolapse or any Pelvic Organ Prolapse Quantification point beyond the hymen. RESULTS: Of 756 women, 633 underwent sacrocolpopexy (83.7%) and 123 (16.3%) underwent uterosacral ligament suspension. In all, 189 (25%) had preoperative Pelvic Organ Prolapse Quantification stage II prolapse, 527 (69.7%) stage III, and 40 (5.3%) stage IV. Patients were predominantly Caucasian (97.3%) with mean age 59.8 ± 9.5 years. Compared to uterosacral ligament suspension patients, more sacrocolpopexy patients had undergone prior prolapse repair (20.9% vs 5.7%, P < .001) and fewer had known diabetes mellitus (7.9% vs 13.8%, P = .034). Characteristics of the groups were otherwise similar. Median follow-up was 41.0 (interquartile range 13.0-88.8) weeks. Stage II prolapse patients had similar recurrence rates following sacrocolpopexy or uterosacral ligament suspension (6.0% vs 5.0, P = 1.00). However, stage III prolapse patients were more likely to experience recurrence following uterosacral ligament suspension (25.7% vs 7.8%, P < .001). This difference persisted after controlling for age, body mass index, smoking, diabetes, and prior prolapse repair (odds ratio, 4.3; 95% confidence interval, 2.2-8.2). There was no discernable difference in recurrence rates for women with stage IV prolapse, although sample size was limited. CONCLUSION: Sacrocolpopexy resulted in a lower prolapse recurrence rate than uterosacral ligament suspension for stage III prolapse. However, there was no difference in recurrence rate among women with preoperative stage II prolapse, suggesting mesh augmentation may not be indicated for these patients. Larger prospective trials are necessary for confirmation.
引用
- Lavelle ES, Giugale LE, Winger DG, et al. Prolapse recurrence following sacrocolpopexy vs uterosacral ligament suspension: a comparison stratified by Pelvic Organ Prolapse Quantification stage. Am J Obstet Gynecol. 2017. PMID: 28951262. doi:10.1016/j.ajog.2017.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。